Show Summary Details
Page of

Medicine quality, physicians, and patients 

Medicine quality, physicians, and patients
Chapter:
Medicine quality, physicians, and patients
Author(s):

Paul N. Newton

DOI:
10.1093/med/9780198746690.003.0016
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 27 February 2021

Poor-quality medicines negate the enormous advantages of modern pharmaceuticals and lead to avoidable morbidity and mortality; loss of confidence in medicines and healthcare systems; economic losses for patients, their families, governments, and the pharmaceutical industry; and—for anti-infectives—engender pathogen drug resistance.

There are many examples of both falsified (due to fraudulent production) and substandard (due to in-factory negligence) medicines, vaccines, diagnostic tests, and devices. New portable diagnostic devices offer hope that they could empower medicine inspectors and pharmacists to obtain objective evidence for selection of suspicious samples for formal analysis. Much greater international effort is needed for the reporting of poor-quality medicines so that detection can be acted upon and patients protected.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.